Amiel Rosales
CEO and Co-Founder
Nubix
nubix-img-2022-arturo-jain-mbn.jpg
Arturo Jain
CTO and Co-Founder
Nubix
/
View from the Top

Timely Radiology Diagnosis Powered by Nubix

By Miriam Bello | Thu, 02/03/2022 - 15:06

Q: In terms of software, how has Nubix grown from 2020 to 2022?

AR: The functionalities of the software have evolved significantly. One of the most outstanding upgrades was the addition of an advanced visor that allows for a 3D image reconstruction. This function was developed to support diagnostics by giving the doctor a better understanding of what the patient is experiencing. For example, the technology made it easier for doctors to interpret radiology results.

AJ: The installation process also changed. Nubix can now be installed and used by any laboratory and hospital. It focuses on the doctors’ practice. The platform allows different actors to communicate with each other. For example, a doctor can use the platform to perform a remote or local interpretation of a radiology study and send the result to the patient, who can later send it to their specialist in real time. This method facilitates a timely diagnosis of diseases that progress quickly or that are highly contagious, like COVID-19. These new additions to the platform have been well received by our client base, which comprises about 60 laboratories and hospitals.

Q: How does Nubix develop its technological solutions?

AR: Every solution we add to the platform is developed in-house following the client’s feedback after they have experienced Nubix. We adapt to each client because we understand that everyone works differently. Nubix’s goal is to facilitate early diagnosis and avoid health complications.

AJ: We are looking forward to introducing and integrating novel, foreign technologies in Mexico to add to Nubix’s capabilities. Nubix operates with radiology tests but behind this solution, there is a complete suite of products that we seek to complement with teleradiology, schedule management and more. We also want to contribute to AI in radiology. To that end, we want to ally with AI developers.

Q: Apart from your growth in capital cities, how has Nubix expanded in rural areas?

AJ: We are achieving our planned expansion in Mexico, which motivates us to keep going and continue approaching all remote areas of the country. For example, we are present in over half of Oaxaca, beyond its capital and large cities. We still depend on digital imaging equipment but we do not require the state-of-the-art equipment that is centralized in major urban areas. We are also well aware of the network limitations in remote areas so we deliver results via text message, which can be easily accessed by doctors at any health center.

AR: Outside Mexico, we are already partnering with third parties in LATAM. This is a natural market for us but we first want to fully understand those regions so our solution is as responsive there as it has been in Mexico.

Q: How do you educate doctors to use your tech and how open are they to adopt it?

AJ: Nubix was designed to be intuitive and easy to use and understand, by both doctors and patients. When we began developing Nubix, we allocated the majority of our resources to understanding what patients, doctors, insurers and laboratories needed from the platform. As a result, we added a QR code in every result that contains the patient’s record to verify it is the right information.

AR: We are also in constant communication with the doctors who work with Nubix. They give us their feedback to improve the platform’s functionalities. We provide training for doctors when we add something new to the platform or when they join Nubix but they are able to operate the platform on their own after a few minutes.

Q: How did the pandemic influence the use of Nubix?

AR: The pandemic propelled the use of tech and of our platform. Accelerated digitalization standardized the use of tech for healthcare to the point where we see digital prescriptions becoming more common and accepted. The same happened with radiology results. Doctors and patients have begun to ask for digital results because they are more convenient. 

AJ: We surveyed 10,000 doctors and patients in the radiology field to evaluate their tech acceptance. The results showed that 90 percent of patients and 81 percent of doctors welcomed digital results.  

Q: What Mexican regulations does Nubix’s tech need to comply with?

AJ: We do not require a sanitary permit to operate but as a healthtech platform, we follow foreign or international regulations that help us provide a better service, even though Mexico does not have a specific regulation for our tech. We follow Mexican regulations regarding electronic clinical records and digital prescriptions because they align with some of our work. We are also following Health Level Seven (HL7) recommendations and work closely with its chapter in Mexico.

AR: We are also founder members of Asociación HealthTech México, an association that seeks to create regulation for healthtech companies because regulating this sector can strengthen its growth.

Q: What elements are needed to make tech a standard practice of medicine?

AJ: Interoperability among all actors is essential because it would allow all companies to offer better service. In radiology, for example, an interconnected system would protect patients from exposure to radiology damage, which occurs when patients do these studies repeatedly. An interconnected system would register the patient’s journey through a health service so every actor can be aware of their state.

Collaboration from all actors in the industry would also be more beneficial than competition; we all have the same goal and can unite to provide better solutions. 

AR: Through an interconnected system, patients will be the owners of their health records and be able to take them to any provider they want to. Patients are the primary actor in healthcare and companies should not forget that. 

 

Nubix is a radiological platform compatible with all operating systems, other PACS and RIS systems for the interpretation and visualization of studies.

Photo by:   Nubix
Miriam Bello Miriam Bello Senior Journalist and Industry Analyst